Patents by Inventor William R. SPREEN

William R. SPREEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230120910
    Abstract: A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
    Type: Application
    Filed: December 22, 2022
    Publication date: April 20, 2023
    Inventors: Herta CRAUWELS, David Margolis, William R. Spreen, Andrew Spaltenstein, Peter Williams
  • Patent number: 11564921
    Abstract: A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: January 31, 2023
    Assignees: ViiV Healthcare Company, Janssen Sciences Ireland Unlimited Company
    Inventors: Herta Crauwels, David Margolis, William R. Spreen, Andrew Spaltenstein, Peter Williams
  • Patent number: 10758531
    Abstract: Methods for treating HIV or AIDS in a human are provided using two drug regimens comprising a bictegravir and rilpivirine, as well as compositions containing such compounds.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: September 1, 2020
    Assignee: ViiV Healthcare Company
    Inventor: William R. Spreen
  • Publication number: 20200147079
    Abstract: A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
    Type: Application
    Filed: July 18, 2018
    Publication date: May 14, 2020
    Inventors: Herta CRAUWELS, David MARGOLIS, William R. SPREEN, Andrew SPALTENSTEIN, Peter WILLIAMS
  • Publication number: 20190142828
    Abstract: Methods for treating HIV or AIDS in a human are provided using two drug regimens comprising a bictegravir and rilpivirine, as well as compositions containing such compounds.
    Type: Application
    Filed: June 30, 2017
    Publication date: May 16, 2019
    Inventor: William R. SPREEN